Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/1811
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAdhikari, R K-
dc.contributor.authorSherchand, J B-
dc.contributor.authorMishra, SR R-
dc.contributor.authorRanabhat, K-
dc.contributor.authorDevkota, P-
dc.contributor.authorMishra, D-
dc.contributor.authorGelal, K-
dc.contributor.authorGhimire, Y C-
dc.contributor.authorMishra, R-
dc.contributor.authorPaudel, R-
dc.contributor.authorWagle, R R-
dc.date.accessioned2023-05-23T09:45:54Z-
dc.date.available2023-05-23T09:45:54Z-
dc.date.issued2014-
dc.identifier.citationAdhikariR. K., SherchandJ. B., MishraS. R., RanabhatK., DevkotaP., MishraD., GhimireY. C., GelalK., MishraR., PaudelR., & WagleR. R. (2014). Factors Determining Non-compliance to Mass Drug Administration for Lymphatic Filariasis Elimination in Endemic Districts of Nepal. Journal of Nepal Health Research Council. https://doi.org/10.33314/jnhrc.v0i0.503en_US
dc.identifier.issnPrint ISSN: 1727-5482; Online ISSN: 1999-6217-
dc.identifier.urihttp://103.69.126.140:8080/handle/20.500.14356/1811-
dc.descriptionOriginal Articleen_US
dc.description.abstractAbstract Background: Background: Mass drug administration (MDA) has been implemented in Nepal since 2003 for elimination of Lymphatic Filariasis (LF). The objective of this study was to explore the factors that determine the noncompliance to MDA for Lymphatic Filariasis elimination in endemic districts of Nepal. Methods: A cross-sectional descriptive study was carried out in three endemic districts namely Dhading, Kapilvastu and Kailali. A total of 900 people were interviewed with structured questionnaire. Results: The result shows that the respondents who knew the DEC contains Albendazole (84.9% vs 42.5%, P<0.001, Adjusted OR=2.89(1.946-4.29) at 95% CI), who were aware of MDA campaign (78.2% vs 33.8% P<0.001, Adjusted OR=2.87(1.73-4.74) at 95% CI), who were visited by health workers at their home during MDA campaign (75.9% vs 24.1% P<0.001, Adjusted OR=4.85(2.448-9.594) at 95% CI) had significantly higher compliance. The respondents who had knowledge of side effects during MDA campaign had lower prevalence of noncompliance as compared who did not have (9.4% vs 33.2%, P<0.001).  Conclusions: Advanced age, primary or below education, ever married, inadequate knowledge on drug, inadequate awareness on MDA, no home visit by health workers during MDA, no belief on MDA drugs were significantly associated with higher non-compliance to MDA. In future, MDA program should focus on awareness campaigns related to composition of drugs, side effects of drugs and compulsory home visit during the campaign. Keywords: Lymphatic Filariasis; Mass drug administration; Non-compliance, Nepalen_US
dc.language.isoenen_US
dc.publisherNepal Health Research Councilen_US
dc.relation.ispartofseriesMay-Aug, 2014;503-
dc.subjectLymphatic Filariasisen_US
dc.subjectMass drug administrationen_US
dc.subjectNon-complianceen_US
dc.subjectNepalen_US
dc.titleFactors Determining Non-compliance to Mass Drug Administration for Lymphatic Filariasis Elimination in Endemic Districts of Nepalen_US
dc.typeJournal Articleen_US
local.journal.categoryOriginal Article-
Appears in Collections:Vol. 12 No. 2 Issue 27, May - Aug 2014

Files in This Item:
File Description SizeFormat 
503-Article Text-878-1-10-20150206.pdfFulltext Download.530.7 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.